Study on Relationships Between Expressions of Matrix Regulated Proteins and Count of Mast Cell in Pancreatic Cancer Tissues

Zhu-lin YANG,Yong-guo LI,Dong-cai LIU,Xing-hui DENG,Xiong-ying MIAO,De-wu ZHONG

DOI: https://doi.org/10.3969/j.issn.1007-9424.2005.05.019

2005-01-01

Abstract:Objective To investigate the expression of extracellular matrix metalloproteinase inducer(EMM-PRIN) ,matrix metalloproteinase-1( MMP1) ,MMP9,tissue inhibitors of metalloproteinase-1( TI MP1) and the mastcell count ( MCC) and to detect their clinicopathologic significance and relationship in pancreatic cancer tissues .Methods I mmunohistochemical method of avidin-biotin complex was used for those 5 targets onthe routinely paraf-fin-embedded sections of surgical resected speci men of 51 cases with pancreatic carcinoma .Results The positiverates of EMMPRIN,MMP1,MMP9and TI MP1were 56 .9%,54 .9%,60 .8%and 49 .0%andits scoring were 2 .5±1 .5 ,2 .3±1 .9 ,2 .4±1 .6 and 1 .9±1 .6 respectively . The mean of MCC was (16 .1±6 .8)/ HPin total cases . Thepositive rates or scorings of EMMPRIN,MMP1,MMP9and MCC were significantly lower in high differentiated orwithout-metastatic cases thanin low differentiated or with-metastatic ones(P0 .05 orP0 .01) ,and those targets(except MCC and scoring of MMP9) of middle differentiated ones were lower than those of lowdifferentiated whilethat of TI MP1was opposite(P0 .01) . The MCC showed significantly higher in the positive cases of EMMPRIN,MMP1and MMP9or negative cases of TI MP1thaninthe negative ones of EMMPRIN, MMP1and MMP9or positiveones of TI MP1.The closely positive correlations were found among the MCCand the scoring of EMMPRIN, MMP1and MMP9.The closely negative correlations existed among the scoring of TI MP1and the other four targets .Conclu-sion The MCCand the expressions of EMMPRIN, MMP1, MMP9and TI MP1might bei mportant biological mark-ers for reflecting the progression and the prognosis of pancreatic carcinoma . They might have co-regulated effects onthe potentials of invasion and metastasis of pancreatic carcinoma or other malignant lesions .